Additionally, DNA methylation and MED12 mutation together constitute a complex regulatory network that affects progesterone/PR-mediated RANKL gene expression [120,121], with an important role in activating stem cell proliferation and leiomyoma development [121]. Here, MED12 is linked to leiomyoma.